Variant report
Variant | nsv528484 |
---|---|
Chromosome Location | chr6:44520451-44524173 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:44499633..44501812-chr6:44521351..44523786,2 | K562 | blood: | |
2 | chr6:44518479..44520787-chr6:44537963..44540818,2 | K562 | blood: | |
3 | chr6:44521774..44524426-chr6:44524796..44527777,2 | K562 | blood: | |
4 | chr6:44500312..44506091-chr6:44519423..44524807,5 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AARS2-2 | chr6:44520550-44521019 | NONHSAT112964 |
2 | lnc-CDC5L-4 | chr6:44519314-44521018 | NONHSAT112966 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1322650 | chr6:44520451-44520452 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs570226688 | chr6:44520486-44520487 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs531177985 | chr6:44520546-44520547 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs112992947 | chr6:44520552-44520553 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs146144771 | chr6:44520636-44520637 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs558605016 | chr6:44520657-44520658 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs535789428 | chr6:44520715-44520716 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs553663078 | chr6:44520826-44520827 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs565901976 | chr6:44520832-44520833 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs571892058 | chr6:44520836-44520837 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs539660151 | chr6:44520923-44520924 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs558258049 | chr6:44520943-44520944 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs527330107 | chr6:44520944-44520945 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs148110716 | chr6:44520989-44520990 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs374841145 | chr6:44520998-44520999 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs368010860 | chr6:44521012-44521013 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs189487534 | chr6:44521057-44521058 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181542754 | chr6:44521062-44521063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186409529 | chr6:44521070-44521071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574245818 | chr6:44521071-44521072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541735167 | chr6:44521090-44521091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs114825852 | chr6:44521101-44521102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138972758 | chr6:44521118-44521119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs371972024 | chr6:44521147-44521148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375280097 | chr6:44521224-44521225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs188837249 | chr6:44521231-44521232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563790771 | chr6:44521357-44521358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115207704 | chr6:44521363-44521364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549356994 | chr6:44521442-44521443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs114580396 | chr6:44521446-44521447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs78053557 | chr6:44521473-44521474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs35469609 | chr6:44521516-44521517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs386406900 | chr6:44521517-44521518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375243480 | chr6:44521524-44521525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs76164387 | chr6:44521530-44521531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370515477 | chr6:44521531-44521532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373418443 | chr6:44521532-44521533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560770681 | chr6:44521554-44521555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565858438 | chr6:44521565-44521566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181567353 | chr6:44521579-44521580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539596208 | chr6:44521583-44521584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551614084 | chr6:44521626-44521627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs116009279 | chr6:44521644-44521645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs9472299 | chr6:44521647-44521648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs116322252 | chr6:44521649-44521650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs117268409 | chr6:44521656-44521657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs150852707 | chr6:44521668-44521669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574011123 | chr6:44521678-44521679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534722056 | chr6:44521679-44521680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553600935 | chr6:44521734-44521735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Osteosarcoma | 21197465 | CNVD |
Gastric cancer | 24379144 | CNVD |
Neuroblastoma | 18923191 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21364760 | CNVD |
Colorectal cancer | 16790693 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Chordoma | 18071362 | CNVD |
Follicular lymphoma | 16790693 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Neurocytoma | 17123091 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Ovarian cancer | 20844748 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:44513400-44523800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr6:44520600-44526600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
3 | chr6:44522400-44523000 | Enhancers | Ovary | ovary |
4 | chr6:44522400-44523200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr6:44522400-44523200 | Enhancers | Fetal Muscle Leg | muscle |
6 | chr6:44522400-44523200 | Enhancers | HSMMtube | muscle |
7 | chr6:44522600-44522800 | Bivalent Enhancer | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr6:44522600-44522800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
9 | chr6:44522600-44523000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr6:44523000-44531000 | Weak transcription | Ovary | ovary |
11 | chr6:44523200-44526200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr6:44523600-44524600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr6:44523800-44524000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr6:44523800-44524000 | Enhancers | Gastric | stomach |
15 | chr6:44523800-44524000 | Enhancers | Pancreas | Pancrea |
16 | chr6:44523800-44524200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
17 | chr6:44523800-44527200 | Enhancers | Primary hematopoietic stem cells | blood |
18 | chr6:44523800-44527600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
19 | chr6:44524000-44525000 | Weak transcription | Pancreas | Pancrea |
20 | chr6:44524000-44527400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
21 | chr6:44524000-44531000 | Weak transcription | Gastric | stomach |